Advanced Enzyme Technologies Limited has informed the Exchange regarding Change in Auditors of the company.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advanced Enzyme Technologies reported FY26 consolidated revenue of Rs 7,457.57 million, up 17% from Rs 6,369.10 million in FY25. Profit after tax grew 29.6% to Rs 1,736.08 million from Rs 1,339.74 million, with EPS at Rs 15.08 versus Rs 11.72. The Board recommended a final dividend of Rs 1.35 per share (67.5% on face value Rs 2) but deferred any interim dividend, stating they want to preserve capital for potential strategic actions. MSKA & Associates LLP was reappointed as statutory auditors for a second 5-year term. The auditor issued an unmodified (clean) opinion on the financial statements.
Strong financial performance with nearly 30% PAT growth demonstrates operational efficiency. The deferred interim dividend despite healthy cash flows signals potential strategic plans ahead. Clean audit opinion with no qualifications is positive for investor confidence.